Primary sclerosing cholangitis (PSC) is one of those Step diseases that looks deceptively simple (“beading on ERCP”) but hides a ton of high-yield connections—especially to ulcerative colitis and cholangiocarcinoma. If you can explain why PSC causes cholestasis, how it shows up in labs and imaging, and what it predisposes to, you’ll pick up easy points across GI, pathology, and even immunology.
What Is Primary Sclerosing Cholangitis (PSC)?
PSC is a chronic, progressive cholestatic liver disease characterized by inflammation, fibrosis, and stricturing of the intrahepatic and/or extrahepatic bile ducts.
Key Step framing:
- Inflammation + fibrosis → multifocal bile duct strictures
- Strictures → obstructed bile flow → cholestasis
- Chronic injury → biliary cirrhosis + malignancy risk
Pathophysiology (What’s Actually Happening?)
PSC is thought to be immune-mediated (exact trigger unclear), strongly linked to IBD.
The core mechanism
- Chronic bile duct inflammation (lymphocytic infiltrates)
- Periductal concentric (“onion-skin”) fibrosis → narrowing/obliteration of ducts
- Leads to:
- Cholestasis (bile can’t get out)
- Biliary cirrhosis over time
- Ascending cholangitis risk due to stasis and bacterial overgrowth
The classic pathology buzzword
- “Onion-skin” periductal fibrosis (very Step 1)
First Aid cross-reference (GI—Hepatobiliary): PSC is typically listed under cholestatic patterns and biliary tract disease, emphasizing UC association, p-ANCA, beading, cholangiocarcinoma risk.
Epidemiology & High-Yield Associations
The big association: Ulcerative colitis
- PSC is strongly associated with ulcerative colitis (more than Crohn).
- Important nuance: PSC can occur even if UC symptoms are mild.
Antibodies
- Often p-ANCA positive (not diagnostic, but classic)
Cancer risks (very testable)
PSC increases risk of:
- Cholangiocarcinoma (major one)
- Gallbladder carcinoma
- Colorectal cancer (especially PSC + UC combo)
- Hepatocellular carcinoma (via cirrhosis)
Board-style pearl: In a patient with PSC who develops worsening jaundice, weight loss, RUQ pain, or rising CA 19-9, think cholangiocarcinoma.
Clinical Presentation
Many patients are asymptomatic early
PSC is often found because of cholestatic labs on routine testing, especially in an IBD patient.
Symptoms when present
- Fatigue
- Pruritus (cholestasis)
- Jaundice
- RUQ discomfort
- Intermittent fevers/chills if ascending cholangitis develops
Signs of chronic cholestasis/cirrhosis
- Hepatomegaly, splenomegaly
- Stigmata of chronic liver disease (late)
- Fat-soluble vitamin deficiency (A, D, E, K) due to impaired bile delivery to gut
Labs: Recognize the Cholestatic Pattern
PSC typically shows a cholestatic liver enzyme pattern:
| Finding | Expected Direction | Why it matters for Step |
|---|---|---|
| Alkaline phosphatase (ALP) | ↑↑ | Cholestasis marker (bile duct injury) |
| GGT | ↑ | Helps confirm hepatic source of high ALP |
| Bilirubin | ↑ (variable) | May rise with progression/obstruction |
| AST/ALT | Mild ↑ | Not the dominant pattern |
High-yield contrast:
- PSC/PBC = cholestatic (ALP high)
- Viral/ischemic/toxic hepatitis = hepatocellular (AST/ALT very high)
Diagnosis: Imaging Is the Money Shot
Best initial/confirmatory imaging (typical Step approach)
- MRCP (noninvasive) or ERCP (invasive, also therapeutic)
- Classic finding: “Beading” of the bile ducts due to alternating strictures and dilation
ERCP/MRCP hallmark:
- Multifocal strictures + segmental dilations → beaded appearance
Histology
Not always necessary if imaging is classic, but pathology is Step-relevant:
- Periductal onion-skin fibrosis
- Progressive duct obliteration → biliary cirrhosis
Typical clinical vignette
Young to middle-aged man with UC, pruritus, cholestatic labs, and beading on ERCP/MRCP.
PSC vs PBC (High-Yield Table)
These two are constantly compared on exams.
| Feature | PSC | PBC |
|---|---|---|
| Typical patient | Man with UC | Middle-aged woman |
| Autoantibodies | p-ANCA (assoc.) | AMA (anti-mitochondrial) |
| Location | Intra + extrahepatic ducts | Intrahepatic ducts |
| Imaging | Beading on MRCP/ERCP | Often normal ducts; diagnosis by serology/biopsy |
| Histology | Onion-skin periductal fibrosis | Destruction of intrahepatic ducts; granulomas sometimes noted |
| Cancer risk | Cholangiocarcinoma, gallbladder ca, CRC | HCC via cirrhosis (less cholangioca emphasis) |
| Treatment theme | Manage cholestasis; transplant definitive | Ursodeoxycholic acid often used |
Step trap: Ursodeoxycholic acid is classically emphasized for PBC. In PSC, meds may improve labs/symptoms but do not reliably prevent progression—transplant is the definitive option for advanced disease.
Complications You Should Memorize
1) Cholangiocarcinoma
- A top-tier PSC association
- Suspect with systemic symptoms, worsening jaundice, RUQ pain, or rising tumor markers (e.g., CA 19-9)
2) Recurrent ascending cholangitis
- Bile stasis predisposes to infection
- Fever + RUQ pain + jaundice (Charcot triad) may show up
3) Cirrhosis and portal hypertension
- Varices, ascites, splenomegaly (late)
4) Fat-soluble vitamin deficiency
- Especially with long-standing cholestasis:
- Vitamin K deficiency → ↑ PT/INR (bleeding tendency)
5) Increased colorectal cancer risk (PSC + UC)
- This is high yield clinically and on exams:
- PSC + UC = higher CRC risk than UC alone
- Requires enhanced colon cancer surveillance in real life
Treatment (Step-Relevant, Reality-Based)
There is no proven medical therapy that reliably stops progression of PSC. Management focuses on symptoms, complications, and transplant when appropriate.
Symptom control
- Pruritus:
- Cholestyramine (bile acid sequestrant) is a classic choice
- Rifampin or naltrexone may be used in practice (less Step-core)
Managing strictures and cholangitis
- ERCP can be used to dilate dominant strictures and relieve obstruction
- Antibiotics for ascending cholangitis (supportive detail)
Definitive therapy
- Liver transplant for advanced disease
- Indications include decompensated cirrhosis, recurrent cholangitis, intractable pruritus, etc.
High-yield point: Even after transplant, PSC can recur (less commonly tested, but worth knowing).
How PSC Shows Up in USMLE-Style Questions
Pattern recognition checklist
If you see:
- UC history
- Pruritus + fatigue
- ALP >> AST/ALT
- MRCP/ERCP beading → Answer is Primary sclerosing cholangitis
Common “next step” prompts
- “Most likely diagnosis?” → PSC
- “Most likely associated condition?” → Ulcerative colitis
- “Most likely autoantibody?” → p-ANCA
- “Most likely complication?” → Cholangiocarcinoma
- “Most definitive treatment in advanced disease?” → Liver transplant
First Aid-Style Rapid Review (Ultra High-Yield)
- PSC: inflammation + fibrosis of bile ducts → multifocal strictures
- Association: Ulcerative colitis, p-ANCA
- Imaging: ERCP/MRCP shows beading
- Histology: onion-skin periductal fibrosis
- Labs: cholestatic pattern (ALP↑)
- Complications: cholangiocarcinoma, recurrent cholangitis, cirrhosis, CRC risk (esp with UC)
- Treatment: symptom/stricture management; transplant is definitive